Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Noelle R. J. Thielman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2260-8055; OpenAlex author ID A5062658313. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. Twist1 overexpression models an aggressive subtype of pancreatic ductal adenocarcinoma in vivo. Co-author DOI 10.1038/s41684-026-01729-2↗
  2. Norepinephrine mediates adrenergic receptor transcription and oncogenic gene expression in pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.jbior.2025.101097↗
  3. Semaphorin 3D promotes pancreatic ductal adenocarcinoma progression and metastasis through macrophage reprogramming. Co-author DOI 10.1126/sciadv.adp0684↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Henry H Brak · 1 shared paper, 2025 · strength 0.54
  2. Lei Zheng · 2 shared papers, 2024–2026 · strength 0.37
  3. William L. Hwang · 1 shared paper, 2026 · strength 0.20
  4. Phuoc Tho Tran · 1 shared paper, 2026 · strength 0.20
  5. Muhammad Ajmal Khan · 1 shared paper, 2026 · strength 0.20
  6. Ryan Jin-hyung Park · 1 shared paper, 2026 · strength 0.20
  7. Jiayu Chen · 1 shared paper, 2026 · strength 0.20
  8. Audrey M. Lafargue · 1 shared paper, 2026 · strength 0.20
  9. Kenji Fujiwara · 1 shared paper, 2024 · strength 0.17
  10. Wei‐Chih Sun · 1 shared paper, 2024 · strength 0.17
  11. Stephen T. Muth · 1 shared paper, 2024 · strength 0.17
  12. Keyu Li · 1 shared paper, 2024 · strength 0.17
  13. Selina Shiqing K. Teh · 1 shared paper, 2024 · strength 0.17
  14. Xingyi Pan · 1 shared paper, 2024 · strength 0.17
  15. Elizabeth M. Jaffee · 1 shared paper, 2024 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.